Works by Kenderian, Saad S.

Results: 34

Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation‐Wide Study.

Published in:

American Journal of Hematology, 2025, v. 100, n. 9, p. 1678, doi. 10.1002/ajh.27747

By:

Tsang, Mazie;
Hampel, Paul J.;
Rabe, Kari G.;
Brieghel, Christian;
Ding, Wei;
Leis, Jose F.;
Hilal, Talal;
Kenderian, Saad S.;
Wang, Yucai;
Muchtar, Eli;
Koehler, Amber B.;
Van Dyke, Daniel L.;
Hanson, Curtis A.;
Shi, Min;
Slager, Susan L.;
Kay, Neil E.;
Hjalgrim, Henrik;
Niemann, Carsten U.;
Parikh, Sameer A.;
Rotbain, Emelie C.

Publication type:

Article

Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.

Published in:

American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060

By:

Kosydar, Samuel R.;
Parikh, Sameer A.;
Lester, Scott C.;
Rabe, Kari G.;
Ding, Wei;
Burlile, Jessica F.;
Kenderian, Saad S.;
Wang, Yucai;
Muchtar, Eli;
Koehler, Amber B.;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil E.;
Call, Timothy G.;
Breen, William G.;
Hampel, Paul J.

Publication type:

Article

PET imaging of differentiated thyroid cancer with thyrotropin-alfa.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-94923-0

By:

Gimblet, Grayson R.;
Reddy, Pratheek;
Holland, Michelle M.;
Houson, Hailey A.;
Whitt, Jason;
Copland, John A.;
Kenderian, Saad S.;
Jaskula-Sztul, Renata;
Lapi, Suzanne E.

Publication type:

Article

CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies.

Published in:

AAPS Journal, 2019, v. 21, n. 3, p. N.PAG, doi. 10.1208/s12248-019-0322-1

By:

Mochel, Jonathan P.;
Ekker, Stephen C.;
Johannes, Chad M.;
Jergens, Albert E.;
Allenspach, Karin;
Bourgois-Mochel, Agnes;
Knouse, Michael;
Benzekry, Sebastien;
Wierson, Wesley;
LeBlanc, Amy K.;
Kenderian, Saad S.

Publication type:

Article

Chimeric Antigen Receptor T‐Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside.

Published in:

CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 537, doi. 10.1111/cts.12586

By:

Rodriguez‐Cartagena, Luis G.;
Bowles, Bradley S.;
Kurani, Shaheen S.;
Windebank, Anthony J.;
Kenderian, Saad S.;
Greenberg‐Worisek, Alexandra J.

Publication type:

Article

Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357

By:

Hampel, Paul J.;
Rabe, Kari G.;
Call, Timothy G.;
Ding, Wei;
Leis, Jose F.;
Kenderian, Saad S.;
Muchtar, Eli;
Wang, Yucai;
Koehler, Amber B.;
Parrondo, Ricardo;
Schwager, Susan M.;
Shi, Min;
Braggio, Esteban;
Slager, Susan L.;
Kay, Neil E.;
Parikh, Sameer A.

Publication type:

Article

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Published in:

British Journal of Haematology, 2018, v. 183, n. 3, p. 421, doi. 10.1111/bjh.15545

By:

Hampel, Paul J.;
Larson, Melissa C.;
Kabat, Brian;
Call, Timothy G.;
Ding, Wei;
Kenderian, Saad S.;
Bowen, Deborah;
Boysen, Justin;
Schwager, Susan M.;
Leis, Jose F.;
Chanan‐Khan, Asher A.;
Muchtar, Eli;
Hanson, Curtis A.;
Slager, Susan L.;
Kay, Neil E.;
Chaffee, Kari G.;
Shanafelt, Tait D.;
Parikh, Sameer A.

Publication type:

Article

Clonal dynamics of Richter transformation in chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3282

By:

Wang, Hanyin;
Tian, Shulan;
Secreto, Charla R.;
Sinha, Sutapa;
Shi, Min;
Call, Timothy;
Wang, Yucai;
Parikh, Sameer A.;
Kenderian, Saad S.;
He, Rong;
Leis, Jose F.;
VanDyke, Daniel L.;
Klee, Eric W.;
Slager, Susan L.;
Braggio, Esteban;
Yan, Huihuang;
Ding, Wei

Publication type:

Article

Human chimeric antigen receptor macrophages for cancer immunotherapy.

Published in:

Nature Biotechnology, 2020, v. 38, n. 8, p. 947, doi. 10.1038/s41587-020-0462-y

By:

Klichinsky, Michael;
Ruella, Marco;
Shestova, Olga;
Lu, Xueqing Maggie;
Best, Andrew;
Zeeman, Martha;
Schmierer, Maggie;
Gabrusiewicz, Konrad;
Anderson, Nicholas R.;
Petty, Nicholas E.;
Cummins, Katherine D.;
Shen, Feng;
Shan, Xinhe;
Veliz, Kimberly;
Blouch, Kristin;
Yashiro-Ohtani, Yumi;
Kenderian, Saad S.;
Kim, Miriam Y.;
O'Connor, Roddy S.;
Wallace, Stephen R.

Publication type:

Article

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.

Published in:

Oncologist, 2020, v. 25, n. 11, p. 974, doi. 10.1634/theoncologist.2020-0388

By:

Hampel, Paul J.;
Call, Timothy G.;
Rabe, Kari G.;
Ding, Wei;
Muchtar, Eli;
Kenderian, Saad S.;
Wang, Yucai;
Leis, Jose F.;
Witzig, Thomas E.;
Koehler, Amber B.;
Fonder, Amie L.;
Schwager, Susan M.;
Van Dyke, Daniel L.;
Braggio, Esteban;
Slager, Susan L.;
Kay, Neil E.;
Parikh, Sameer A.

Publication type:

Article

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 6, p. 1376, doi. 10.1080/10428194.2016.1251592

By:

Finnes, Heidi D.;
Chaffee, Kari G.;
Call, Timothy G.;
Ding, Wei;
Kenderian, Saad S.;
Bowen, Deborah A.;
Conte, Michael;
McCullough, Kristen B.;
Merten, Julianna A.;
Bartoo, Gabriel T.;
Smith, Matthew D.;
Leis, Jose;
Chanan-Khan, Asher;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil E.;
Shanafelt, Tait D.;
Parikh, Sameer A.

Publication type:

Article

Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

Published in:

American Journal of Hematology, 2022, v. 97, n. 1, p. 90, doi. 10.1002/ajh.26388

By:

Muchtar, Eli;
Koehler, Amber B.;
Johnson, Michael J.;
Rabe, Kari G.;
Ding, Wei;
Call, Timothy G.;
Leis, Jose F.;
Kenderian, Saad S.;
Hayman, Suzanne R.;
Wang, Yucai;
Hampel, Paul J.;
Holets, Matthew A.;
Darby, Heather C.;
Slager, Susan L.;
Kay, Neil E.;
Miao, Congrong;
Canniff, Jennifer;
Whitaker, Jennifer A.;
Levin, Myron J.;
Schmid, D. Scott

Publication type:

Article

The prognostic significance of del6q23 in chronic lymphocytic leukemia.

Published in:

American Journal of Hematology, 2021, v. 96, n. 6, p. E203, doi. 10.1002/ajh.26168

By:

Audil, Hadiyah Y.;
Hampel, Paul J.;
Van Dyke, Daniel L.;
Achenbach, Sara J.;
Rabe, Kari G.;
Smoley, Stephanie A.;
Call, Timothy G.;
Ding, Wei;
Shi, Min;
Hanson, Curtis A.;
Wang, Yucai;
Muchtar, Eli;
Koehler, Amber B.;
Schwager, Susan M.;
Leis, Jose F.;
Braggio, Esteban;
Slager, Susan L.;
Kay, Neil E.;
Kenderian, Saad S.;
Parikh, Sameer A.

Publication type:

Article

Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.

Published in:

American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922

By:

Heybeli, Cihan;
Sridharan, Meera;
Alkhateeb, Hassan B.;
Villasboas Bisneto, Jose C.;
Buadi, Francis K.;
Chen, Dong;
Dingli, David;
Dispenzieri, Angela;
Gertz, Morie A.;
Go, Ronald S.;
Hashmi, Shahrukh K.;
Hayman, Suzanne R.;
Hogan, William J.;
Inwards, David J.;
Kenderian, Saad S.;
Kumar, Shaji K.;
Litzow, Mark R.;
Porrata, Luis F.;
Lacy, Martha Q.;
Micallef, Ivana N.

Publication type:

Article

Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

Published in:

American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690

By:

Hampel, Paul J.;
Call, Timothy G.;
Ding, Wei;
Muchtar, Eli;
Kenderian, Saad S.;
Wang, Yucai;
Leis, Jose F.;
Witzig, Thomas E.;
Koehler, Amber B.;
Fonder, Amie L.;
Schwager, Susan M.;
Rabe, Kari G.;
Van Dyke, Daniel L.;
Braggio, Esteban;
Slager, Susan L.;
Kay, Neil E.;
Parikh, Sameer A.

Publication type:

Article

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

Published in:

American Journal of Hematology, 2019, v. 94, n. 3, p. 338, doi. 10.1002/ajh.25385

By:

Fang, Hong;
Reichard, Kaaren K.;
Rabe, Kari G.;
Hanson, Curtis A.;
Call, Timothy G.;
Ding, Wei;
Kenderian, Saad S.;
Muchtar, Eli;
Schwager, Susan M.;
Leis, Jose F.;
Chanan‐Khan, Asher A.;
Slager, Susan L.;
Braggio, Esteban;
Smoley, Stephanie A.;
Kay, Neil E.;
Shanafelt, Tait D.;
Van Dyke, Daniel L.;
Parikh, Sameer A.

Publication type:

Article

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Published in:

American Journal of Hematology, 2017, v. 92, n. 12, p. 1362, doi. 10.1002/ajh.24915

By:

Hampel, Paul J.;
Chaffee, Kari G.;
King, Rebecca L.;
Simonetto, Douglas;
Larson, Melissa C.;
Achenbach, Sara;
Call, Timothy G.;
Ding, Wei;
Kenderian, Saad S.;
Leis, Jose F.;
Chanan-Khan, Asher A.;
Bowen, Deborah A.;
Conte, Michael J.;
Schwager, Susan M.;
Hanson, Curtis A.;
Slager, Susan L.;
Kay, Neil E.;
Shanafelt, Tait D.;
Parikh, Sameer A.

Publication type:

Article

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

Published in:

Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998

By:

Parikh, Sameer A.;
Achenbach, Sara J.;
Call, Timothy G.;
Rabe, Kari G.;
Ding, Wei;
Leis, Jose F.;
Kenderian, Saad S.;
Chanan‐Khan, Asher A.;
Koehler, Amber B.;
Schwager, Susan M.;
Muchtar, Eli;
Fonder, Amie L.;
McCullough, Kristen B.;
Nedved, Adrienne N.;
Smith, Matthew D.;
Slager, Susan L.;
Kay, Neil E.;
Finnes, Heidi D.;
Shanafelt, Tait D.

Publication type:

Article

CRISPR Takes the Front Seat in CART-Cell Development.

Published in:

BioDrugs, 2021, v. 35, n. 2, p. 113, doi. 10.1007/s40259-021-00473-y

By:

Manriquez-Roman, Claudia;
Siegler, Elizabeth L.;
Kenderian, Saad S.

Publication type:

Article

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6

By:

Hampel, Paul J.;
Rabe, Kari G.;
Call, Timothy G.;
Ding, Wei;
Leis, Jose F.;
Chanan-Khan, Asher A.;
Kenderian, Saad S.;
Muchtar, Eli;
Wang, Yucai;
Ailawadhi, Sikander;
Koehler, Amber B.;
Parrondo, Ricardo;
Schwager, Susan M.;
Sher, Taimur;
Hanson, Curtis A.;
Shi, Min;
Van Dyke, Daniel L.;
Braggio, Esteban;
Slager, Susan L.;
Kay, Neil E.

Publication type:

Article

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.

Published in:

2022

By:

Alkhateeb, Hassan B.;
Mohty, Razan;
Greipp, Patricia;
Bansal, Radhika;
Hathcock, Matthew;
Rosenthal, Allison;
Murthy, Hemant;
Kharfan-Dabaja, Mohamed;
Bisneto Villasboas, Jose C.;
Bennani, Nora;
Ansell, Stephen M.;
Patnaik, Mrinal M.;
Litzow, Mark R.;
He, Rong;
Chen, Dong;
Al-Kali, Aref;
Kenderian, Saad S.;
Lin, Yi;
Shah, Mithun Vinod

Publication type:

Letter

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Published in:

Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6

By:

King, Rebecca L.;
Gupta, Alia;
Kurtin, Paul J.;
Ding, Wei;
Call, Timothy G.;
Rabe, Kari G.;
Kenderian, Saad S.;
Leis, Jose F.;
Wang, Yucai;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil. E.;
Koehler, Amber;
Ansell, Stephen M.;
Inwards, David J.;
Habermann, Thomas M.;
Shi, Min;
Hanson, Curtis A.;
Howard, Matthew T.;
Parikh, Sameer A.

Publication type:

Article

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index.

Published in:

2021

By:

Wang, Yucai;
Achenbach, Sara J.;
Rabe, Kari G.;
Shanafelt, Tait D.;
Call, Timothy G.;
Ding, Wei;
Kenderian, Saad S.;
Muchtar, Eli;
Leis, Jose F.;
Koehler, Amber B.;
Schwager, Susan M.;
Cerhan, James R.;
Slager, Susan L.;
Kay, Neil E.;
Parikh, Sameer A.

Publication type:

Letter

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5

By:

Wang, Yucai;
Sinha, Sutapa;
Wellik, Linda E.;
Secreto, Charla R.;
Rech, Karen L.;
Call, Timothy G.;
Parikh, Sameer A.;
Kenderian, Saad S.;
Muchtar, Eli;
Hayman, Suzanne R.;
Koehler, Amber B.;
Van Dyke, Daniel L.;
Leis, Jose F.;
Slager, Susan L.;
Dong, Haidong;
Kay, Neil E.;
He, Rong;
Ding, Wei

Publication type:

Article

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

Published in:

2021

By:

Hampel, Paul J.;
Parikh, Sameer A.;
Call, Timothy G.;
Shah, Mithun V.;
Bennani, N. Nora;
Al-Kali, Aref;
Rabe, Kari G.;
Wang, Yucai;
Muchtar, Eli;
Leis, Jose F.;
Kenderian, Saad S.;
Koehler, Amber B.;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil E.;
Hanson, Curtis A.;
Van Dyke, Daniel L.;
Shi, Min;
Ding, Wei

Publication type:

Letter

Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950

By:

Wang, Hanyin;
Tian, Shulan;
Zhao, Qing;
Blumenschein, Wendy;
Yearley, Jennifer H.;
Secreto, Charla R.;
Sinha, Sutapa;
Call, Timothy G.;
Wang, Yucai;
Parikh, Sameer A.;
Kenderian, Saad S.;
He, Rong;
Leis, Jose F.;
Shi, Min;
Van Dyke, Daniel L.;
Kay, Neil E.;
Slager, Susan L.;
Braggio, Esteban;
Yan, Huihuang;
Ding, Wei

Publication type:

Article

CAR-T Cell Therapy: the Efficacy and Toxicity Balance.

Published in:

Current Hematologic Malignancy Reports, 2023, v. 18, n. 2, p. 9, doi. 10.1007/s11899-023-00687-7

By:

Chohan, Karan L.;
Siegler, Elizabeth L.;
Kenderian, Saad S.

Publication type:

Article

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

Published in:

2016

By:

Ruella, Marco;
Barrett, David M.;
Kenderian, Saad S.;
Shestova, Olga;
Hofmann, Ted J.;
Perazzelli, Jessica;
Klichinsky, Michael;
Aikawa, Vania;
Nazimuddin, Farzana;
Kozlowski, Miroslaw;
Scholler, John;
Lacey, Simon F.;
Melenhorst, Jan J.;
Morrissette, Jennifer J. D.;
Christian, David A.;
Hunter, Christopher A.;
Kalos, Michael;
Porter, David L.;
June, Carl H.;
Grupp, Stephan A.

Publication type:

journal article

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies.

Published in:

Frontiers in Immunology, 2020, p. N.PAG, doi. 10.3389/fimmu.2020.01973

By:

Siegler, Elizabeth L.;
Kenderian, Saad S.

Publication type:

Article

Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 3, p. 389, doi. 10.1080/10428194.2023.2285236

By:

Chohan, Karan L.;
Bansal, Radhika;
Hathcock, Matthew A.;
Paludo, Jonas;
Bennani, Nora N.;
Johnston, Patrick B.;
Khurana, Arushi;
Durani, Urshila;
Wang, Yucai;
Ruff, Michael W.;
Villasboas Bisneto, Jose C.;
Ansell, Stephen M.;
Lin, Yi;
Kenderian, Saad S.

Publication type:

Article

Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies.

Published in:

Leukemia & Lymphoma, 2021, v. 62, n. 9, p. 2052, doi. 10.1080/10428194.2021.1894648

By:

Sakemura, Reona;
Cox, Michelle J.;
Hefazi, Mehrdad;
Siegler, Elizabeth L.;
Kenderian, Saad S.

Publication type:

Article

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2383, doi. 10.1080/10428194.2020.1768384

By:

Koehler, Amber B.;
Leung, Nelson;
Call, Timothy G.;
Rabe, Kari G.;
Achenbach, Sara J.;
Ding, Wei;
Kenderian, Saad S.;
Leis, Jose F.;
Wang, Yucai;
Muchtar, Eli;
Hayman, Suzanne R.;
Hampel, Paul J.;
Finnes, Heidi D.;
Schwager, Susan M.;
Slager, Susan L.;
Kay, Neil E.;
Parikh, Sameer A.

Publication type:

Article

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268

By:

Hampel, Paul J.;
Ding, Wei;
Call, Timothy G.;
Rabe, Kari G.;
Kenderian, Saad S.;
Witzig, Thomas E.;
Muchtar, Eli;
Leis, Jose F.;
Chanan-Khan, Asher A.;
Koehler, Amber B.;
Fonder, Amie L.;
Schwager, Susan M.;
Slager, Susan L.;
Shanafelt, Tait D.;
Kay, Neil E.;
Parikh, Sameer A.

Publication type:

Article

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

Published in:

Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3

By:

Archibald, William J.;
Rabe, Kari G.;
Kabat, Brian F.;
Herrmann, Joerg;
Ding, Wei;
Kay, Neil E.;
Kenderian, Saad S.;
Muchtar, Eli;
Leis, Jose F.;
Wang, Yucai;
Chanan-Khan, Asher A.;
Schwager, Susan M.;
Koehler, Amber B.;
Fonder, Amie L.;
Slager, Susan L.;
Shanafelt, Tait D.;
Call, Timothy G.;
Parikh, Sameer A.

Publication type:

Article